Bank of New York Mellon
AGN

Bank of New York Mellon’s Allergan plc AGN Stock Holding History

Bank of New York Mellon’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,697,669
Closed -$478M – 4214
2020
Q1 		$478M Buy
2,697,669
+175,753
+7% +$33.1M 0.16% 133
2019
Q4 		$482M Sell
2,521,916
-4,133
-0.2% -$746K 0.12% 155
2019
Q3 		$425M Sell
2,526,049
-323,948
-11% -$52.8M 0.12% 172
2019
Q2 		$477M Sell
2,849,997
-153,385
-5% -$21.2M 0.13% 150
2019
Q1 		$440M Buy
3,003,382
+22,422
+0.8% +$3.25M 0.12% 154
2018
Q4 		$398M Sell
2,980,960
-656,894
-18% -$108M 0.12% 152
2018
Q3 		$693M Buy
3,637,854
+92,297
+3% +$17M 0.18% 108
2018
Q2 		$591M Buy
3,545,557
+99,490
+3% +$16M 0.16% 120
2018
Q1 		$580M Buy
3,446,067
+109,286
+3% +$18.3M 0.16% 126
2017
Q4 		$546M Sell
3,336,781
-76,750
-2% -$13.8M 0.14% 141
2017
Q3 		$700M Sell
3,413,531
-33,677
-1% -$7.83M 0.19% 99
2017
Q2 		$838M Sell
3,447,208
-203,947
-6% -$47.9M 0.24% 80
2017
Q1 		$872M Sell
3,651,155
-241,206
-6% -$56.2M 0.24% 79
2016
Q4 		$817M Sell
3,892,361
-498,033
-11% -$103M 0.24% 83
2016
Q3 		$1.01B Buy
4,390,394
+329,024
+8% +$80.4M 0.3% 66
2016
Q2 		$939M Buy
4,061,370
+365
+0% +$84.2K 0.29% 72
2016
Q1 		$1.09B Sell
4,061,005
-562,699
-12% -$161M 0.33% 64
2015
Q4 		$1.44B Sell
4,623,704
-122,224
-3% -$36.4M 0.44% 46
2015
Q3 		$1.29B Sell
4,745,928
-155,495
-3% -$47.8M 0.4% 53
2015
Q2 		$1.49B Sell
4,901,423
-161,150
-3% -$48.1M 0.41% 49
2015
Q1 		$1.51B Buy
5,062,573
+1,276,500
+34% +$364M 0.39% 53
2014
Q4 		$975M Buy
3,786,073
+22,283
+0.6% +$5.57M 0.25% 83
2014
Q3 		$908M Buy
3,763,790
+1,351,107
+56% +$302M 0.25% 85
2014
Q2 		$538M Buy
2,412,683
+90,262
+4% +$18.7M 0.14% 147
2014
Q1 		$478M Sell
2,322,421
-118,572
-5% -$23.5M 0.13% 162
2013
Q4 		$410M Buy
2,440,993
+41,331
+2% +$6.46M 0.11% 181
2013
Q3 		$346M Buy
2,399,662
+277,204
+13% +$36.9M 0.1% 201
2013
Q2 		$268M Buy
+2,122,458
New +$240M 0.08% 237

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Bank of New York Mellon's AGN Position: Q2 2020 in Review

Bank of New York Mellon sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,697,669 shares — an estimated $478M sold.

Bank of New York Mellon first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.51B in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Bank of New York Mellon reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Bank of New York Mellon sold 2,697,669 Allergan plc shares in Q2 2020, an estimated $478M.
  • Bank of New York Mellon first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Bank of New York Mellon's Allergan plc position peaked at $1.51B in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.